Topics
- Insight into the varying regulatory approaches for biosimilars prevailing in different regions
- An overview of the Biosimilars picture across the world
- Background to determine whether entering the biosimilars market is an appropriate strategy for their company
- The commercial situation as it is now and likely to develop in the future
Who should Attend
Executive Directors, Chief Executives, Heads, Vice Presidents and Team Leaders from: Regulatory Affairs, Intellectual Property, Licensing, Business Development, APIs, Manufacturing, Legislation and Policy Advice, Market Strategy, Drug and Safety Assessment.
